David Diamond - 08 Jul 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
Director
Signature
/s/ David Diamond
Issuer symbol
OTLC
Transactions as of
08 Jul 2021
Transactions value $
$0
Form type
4
Filing time
16 Jul 2021, 17:36:50 UTC
Next filing
25 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Stock Options Award $0 +451K $0.00 451K 08 Jul 2021 Common Stock 451K $0.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on the date of grant.